Facial Filler Coverage Will Help Boost Quality Of Life For HIV Patients - CMS
This article was originally published in The Gray Sheet
Executive Summary
In a March 23 decision memo, CMS says it will now cover dermal injections to treat facial lipodystrophy when the stigmatizing side effect of antiretroviral HIV drugs is a significant contributor to a Medicare beneficiary's depression